These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18201375)

  • 1. Tobacco industry issues management organizations: creating a global corporate network to undermine public health.
    McDaniel PA; Intinarelli G; Malone RE
    Global Health; 2008 Jan; 4():2. PubMed ID: 18201375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control.
    Weishaar H; Collin J; Smith K; Grüning T; Mandal S; Gilmore A
    PLoS Med; 2012; 9(6):e1001249. PubMed ID: 22745607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Nordic tobacco interests collaborated with multinational companies to maintain a united front and undermine tobacco control policies.
    Hiilamo H; Glantz SA
    Tob Control; 2013 Mar; 22(2):154-64. PubMed ID: 22199013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared vision, shared vulnerability: A content analysis of corporate social responsibility information on tobacco industry websites.
    McDaniel PA; Cadman B; Malone RE
    Prev Med; 2016 Aug; 89():337-344. PubMed ID: 27261411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco is "our industry and we must support it": Exploring the potential implications of Zimbabwe's accession to the Framework Convention on Tobacco Control.
    Lown EA; McDaniel PA; Malone RE
    Global Health; 2016 Jan; 12():2. PubMed ID: 26754965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco industry attempts to influence and use the German government to undermine the WHO Framework Convention on Tobacco Control.
    Grüning T; Weishaar H; Collin J; Gilmore AB
    Tob Control; 2012 Jan; 21(1):30-8. PubMed ID: 21659448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Public enemy no. 1': Tobacco industry funding for the AIDS response.
    Smith J; Thompson S; Lee K
    SAHARA J; 2016; 13(1):41-52. PubMed ID: 27023371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attempts to undermine tobacco control: tobacco industry "youth smoking prevention" programs to undermine meaningful tobacco control in Latin America.
    Sebrié EM; Glantz SA
    Am J Public Health; 2007 Aug; 97(8):1357-67. PubMed ID: 17600260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation and control: the Tobacco Institute of Australia.
    Carter SM
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii54-60. PubMed ID: 14645949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global leaf companies control the tobacco market in Malawi.
    Otañez MG; Mamudu H; Glantz SA
    Tob Control; 2007 Aug; 16(4):261-9. PubMed ID: 17652242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Using information to shape perception": tobacco industry documents study of the evolution of Corporate Affairs in the Miller Brewing Company.
    McCambridge J; Garry J; Kypri K; Hastings G
    Global Health; 2022 May; 18(1):52. PubMed ID: 35597943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco industry strategies to undermine the 8th World Conference on Tobacco or Health.
    Muggli ME; Hurt RD
    Tob Control; 2003 Jun; 12(2):195-202. PubMed ID: 12773731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco companies' use of developing countries' economic reliance on tobacco to lobby against global tobacco control: the case of Malawi.
    Otañez MG; Mamudu HM; Glantz SA
    Am J Public Health; 2009 Oct; 99(10):1759-71. PubMed ID: 19696392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From transit hub to major supplier of illicit cigarettes to Argentina and Brazil: the changing role of domestic production and transnational tobacco companies in Paraguay between 1960 and 2003.
    Iglesias RM; Gomis B; Carrillo Botero N; Shepherd P; Lee K
    Global Health; 2018 Nov; 14(1):111. PubMed ID: 30454015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking control strategies in developing countries: report of a WHO Expert Committee.
    Masironi R
    World Smoking Health; 1984; 9(1):4-6. PubMed ID: 12179599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing with kreteks: transnational tobacco companies, globalisation, and Indonesia.
    Lawrence S; Collin J
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii96-103. PubMed ID: 15564227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social responsibility in tobacco production? Tobacco companies' use of green supply chains to obscure the real costs of tobacco farming.
    Otañez M; Glantz SA
    Tob Control; 2011 Nov; 20(6):403-11. PubMed ID: 21504915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Manage and mitigate punitive regulatory measures, enhance the corporate image, influence public policy': industry efforts to shape understanding of tobacco-attributable deforestation.
    Lee K; Carrillo Botero N; Novotny T
    Global Health; 2016 Sep; 12(1):55. PubMed ID: 27650401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.